However, down-regulation of HIF1α and GLUT1 are not the only impacts of mTORC1/2 inhibition: whilst MLN0128 monotherapy has marked effects on tumour growth in the KLLUC model, rapamycin fails to effect tumour growth21. The gene discussed is HIF1A; the disease is neoplasm.